Clinical Trials Browser

sotrovimab × Clear all

NCT04870333 2025-06-20

PROTECT-V

Phase 2/3 Completed

COVID-19, Glomerulonephritis, Lupus Erythematosus, Systemic, Neoplasms, Vasculitis

NCT05135650 2025-02-13

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Phase 1 Terminated

20 enrolled 17 charts

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms